MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1581 to 1600 of 166,322 approvalsPage 80 of 8317

Multiple Electrolytes Injection(Ⅱ)

Approval Number: 国药准字H20253253
Registration: Jan 24, 2025
温岭市创新生物医药科技股份有限公司

Amorolfine Hydrochloride Liniment

Approval Number: 国药准字H20253230
Registration: Jan 24, 2025
武汉诺安药业有限公司

Desvenlafaxine Succinate Sustained-release Tablets

Approval Number: 国药准字H20253249
Registration: Jan 24, 2025
宜昌人福药业有限责任公司

Levetiracetam in Sodium Chloride Injection

Approval Number: 国药准字H20253254
Registration: Jan 24, 2025
贵州阜康仁制药有限公司

Dimethyl Fumarate Enteric Capsules

Approval Number: 国药准字H20253259
Registration: Jan 24, 2025
宜昌人福药业有限责任公司

Ibuprofen Concentrated Solution for Injection

Approval Number: 国药准字H20253238
Registration: Jan 24, 2025
西安汉丰药业有限责任公司

Efsubaglutide Alfa Injection

Approval Number: 国药准字S20250009
Registration: Jan 24, 2025
上海银诺医药技术有限公司

Telmisartan and Amlodipine Tablets （Ⅱ）

Approval Number: 国药准字H20253314
Registration: Jan 24, 2025
山西德元堂药业有限公司

Amoxicillin Sodium for Injection

Approval Number: 国药准字H20253299
Registration: Jan 24, 2025
四川制药制剂有限公司

Midazolam Hydrochloride Oral Solution

Approval Number: 国药准字H20253288
Registration: Jan 24, 2025
福安药业集团湖北人民制药有限公司

Cyclopentolate Hydrochloride Eye Drops

Approval Number: 国药准字H20253278
Registration: Jan 24, 2025
山东绅联药业股份有限公司

Dapagliflozin Tablets

Approval Number: 国药准字H20253304
Registration: Jan 24, 2025
河北智恒医药科技股份有限公司

Macrogol Sodium Potassium Powder

Approval Number: 国药准字H20253326
Registration: Jan 24, 2025
圣嘉（滨海）生物医药科技有限公司

Simethicone Emulsion

Approval Number: 国药准字H20253295
Registration: Jan 24, 2025
北京北陆药业股份有限公司

Macrogol Sodium Potassium Powder

Approval Number: 国药准字H20253275
Registration: Jan 24, 2025
浙江国镜药业有限公司

Lidocaine and Prilocaine Cream

Approval Number: 国药准字H20253227
Registration: Jan 24, 2025
苏州二叶制药有限公司

Urapidil Hydrochloride Injection

Approval Number: 国药准字H20253270
Registration: Jan 24, 2025
杭州民生药业股份有限公司

Desvenlafaxine Succinate Sustained-release Tablets

Approval Number: 国药准字H20253251
Registration: Jan 24, 2025
宜昌人福药业有限责任公司

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.